OrthoPediatrics saw the highest growth of 1.99% in patent filings and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of OrthoPediatrics‘s patent filings and grants. Buy the databook here.
OrthoPediatrics has been focused on protecting inventions in United States(US) with four publications in Q2 2024
The United States(US) Patent Office dominates the patent filings with nearly 100% of filings. The United States(US) patent Office are among the top ten patent offices where OrthoPediatrics is filings its patents..
Roger P. Jackson and Johnson & Johnson could be the strongest competitors for OrthoPediatrics
In terms of grant share, OrthoPediatrics stands in eighth position among its competitors. Roger P. Jackson and Johnson & Johnson secured the top positions according to recent patent publication data.
Patents related to healthtech lead OrthoPediatrics's portfolio
OrthoPediatrics has the highest number of patents in healthtech. For healthtech, nearly 100% of patents were filed and no patents were granted in Q2 2024.
Orthopedic devices related patents lead OrthoPediatrics portfolio
OrthoPediatrics has highest number of patents in orthopedic devices.
For comprehensive analysis of OrthoPediatrics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.